Winton Group’s Autolus Therapeutics AUTL Stock Holding History
Bought
Maintained
Sold
Other funds holding AUTL
Winton Group's AUTL Position: Q3 2026 in Review
Winton Group opened a new position in Autolus Therapeutics (AUTL) in Q3 2026: 48,000 shares worth $93.1K. The stake represents ﹤0.01% of the portfolio and ranks #1039 among its holdings.
90 funds tracked by Wall St. Rank hold AUTL as of Q3 2026.
- Winton Group held 48,000 shares of Autolus Therapeutics worth $93.1K as of Q3 2026.
- Autolus Therapeutics was a new Winton Group position in Q3 2026.
- Autolus Therapeutics made up ﹤0.01% of Winton Group's portfolio in Q3 2026, its #1039 holding.
- 90 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q3 2026.
Based on Winton Group's 13F filing for Q3 2026, filed 12 Nov 2026.